Please login to the form below

Not currently logged in
Email:
Password:

plecanatide

This page shows the latest plecanatide news and features for those working in and with pharma, biotech and healthcare.

Shire bags US approval for constipation drug Motegrity

Shire bags US approval for constipation drug Motegrity

It has the same mechanism as Trulance (plecanatide), which was approved by the FDA to treat CIC in January 2017 and brought in around $32m in the same period.

Latest news

  • FDA approves Synergy's constipation drug Trulance FDA approves Synergy's constipation drug Trulance

    Trulance (plecanatide), an orally administered guanylate cyclase C (GC-C) receptor agonist, works locally in the upper gastrointestinal tract to stimulate secretion of intestinal fluid, which helps keep bowel function regular, ... Plecanatide's closest

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics